title: Beneficial effects of oxfenicine on the hypoxic rat atria.
abstract: During hypoxia the isolated rat atria released lactate into the bathing medium and underwent a rise of resting tension and a decline of the peak developed tension and pacemaker frequency. The atria from 24 h fasted rats, which oxidize faster their endogenous triacylglycerol pool, showed greater functional disturbances during hypoxia and a smaller recovery after reoxygenation than those from fed rats. Oxfenicine, which is a selective inhibitor of carnitine palmitoyltransferase I, attenuated the rise of resting tension and improved the post-hypoxic recovery of peak tension in the atria from fasted rats. The decline of the pacemaker frequency as well as the lactate output were not altered by the inhibitor. Present data show that oxfenicine ameliorated some of the hypoxic functional disturbances. Inasmuch lactate output did not change and these effects manifested only in the atria predisposed to the utilization of endogenous lipids, it may be inferred that oxfenicine preserved the atrial functions through the inhibition of fatty acid oxidation.
authors.affiliation: Cátedra de Fisiología, Facultad de Farmacia y Bioquímica, Buenos Aires, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Carregal
authors.forename: A
authors.initials: A
authors.lastname: Varela
authors.forename: V
authors.initials: V
authors.lastname: Dalamon
authors.forename: S
authors.initials: S
authors.lastname: Sacks
authors.forename: E A
authors.initials: EA
authors.lastname: Savino
mesh_terms: D000818:Animals; D016275:Atrial Function; D002334:Carnitine O-Palmitoyltransferase / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005215:Fasting; D005260:Female; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D000860:Hypoxia; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D010100:Oxygen / Q000008:administration & dosage*; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D014280:Triglycerides; C023010:4-hydroxyphenylglycine; D002334:Carnitine O-Palmitoyltransferase; D010100:Oxygen; D005998:Glycine